In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Abstracts include pivotal efficacy and safety data for CSL Behring's long-acting recombinant albumin fusion protein for hemophilia B; CSL Behring's recombinant coagulation factor development program reinforces the company's promise to develop specialty biotherapies that help people with serious medical conditions live full lives